Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
Cancer Research
|
January 22, 2017
Differential PI3Kδ Signaling in CD4<sup>+</sup> T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy
Shamim Ahmad, Rasha Abu-Eid, Rajeev Shrimali, et al.
Cellular Immunology
|
June 1, 2005
L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes
Arnold H Zea, Paulo C Rodriguez, Kirk S Culotta, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models
Manali S Phadke, Jiannong Li, Zhihua Chen, et al.
Journal for Immunotherapy of Cancer
|
August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models
Manali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Cancer Research
|
September 15, 2017
Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance
Rosa A Sierra, Jimena Trillo-Tinoco, Eslam Mohamed, et al.
The Journal of Allergy and Clinical Immunology
|
December 3, 2014
DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4⁺ T-cell function without causing severe combined immunodeficiency
Mohamed A Ghonim, Kusma Pyakurel, Jihang Ju, et al.
Oncoimmunology
|
November 11, 2017
Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
Amir A Al-Khami, Liqin Zheng, Luis Del Valle, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Engineering synthetic agonists for targeted activation of Notch signaling
David H Perez, Daniel Antfolk, Xiomar E Bustos, et al.
Cancer Cell
|
June 15, 2021
Innate immune cells in the tumor microenvironment
Ming O Li, Natalie Wolf, David H Raulet, et al.
Nature Chemical Biology
|
September 24, 2025
Engineering synthetic agonists for targeted activation of Notch signaling
David H Perez, Daniel Antfolk, Shiun Chang, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
Cancer Research
|
January 22, 2017
Differential PI3Kδ Signaling in CD4<sup>+</sup> T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy
Shamim Ahmad, Rasha Abu-Eid, Rajeev Shrimali, et al.
Cellular Immunology
|
June 1, 2005
L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes
Arnold H Zea, Paulo C Rodriguez, Kirk S Culotta, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models
Manali S Phadke, Jiannong Li, Zhihua Chen, et al.
Journal for Immunotherapy of Cancer
|
August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models
Manali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Cancer Research
|
September 15, 2017
Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance
Rosa A Sierra, Jimena Trillo-Tinoco, Eslam Mohamed, et al.
The Journal of Allergy and Clinical Immunology
|
December 3, 2014
DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4⁺ T-cell function without causing severe combined immunodeficiency
Mohamed A Ghonim, Kusma Pyakurel, Jihang Ju, et al.
Oncoimmunology
|
November 11, 2017
Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
Amir A Al-Khami, Liqin Zheng, Luis Del Valle, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
Engineering synthetic agonists for targeted activation of Notch signaling
David H Perez, Daniel Antfolk, Xiomar E Bustos, et al.
Cancer Cell
|
June 15, 2021
Innate immune cells in the tumor microenvironment
Ming O Li, Natalie Wolf, David H Raulet, et al.
Nature Chemical Biology
|
September 24, 2025
Engineering synthetic agonists for targeted activation of Notch signaling
David H Perez, Daniel Antfolk, Shiun Chang, et al.
Page
of 12